Cloud-Based Drug Discovery Platform Market Trends and Competitive Lan FMI | Page 5

Report
Description
Report Description
Cloud-based drug discover platform runs at zero lag time, saving time and giving realtime access to users. This is another reason for the growing adoption of cloud-based drug
discovery platform globally.

Confidentiality and privacy issues continue to impede the growth of the cloud-based drug
discovery platform market. Although many improvements have been made in the recent
past, cyber hacks continue to create apprehension among many pharma players, leading
to stifled adoption.
North America, Japan and Western Europe regions are some of the key players in the
global cloud-based drug discovery platform market. Many pharma companies based in
these regions have already adopted cloud-based drug discovery platform, and it is
anticipated that in the future, more companies will follow suit. The growth of the market
in Asia Pacific excluding Japan (APEJ) is expected to gain momentum during the forecast
period 2016-2026.
Request for TOC: http://www.futuremarketinsights.com/toc/rep-gb-1591
Cloud-Based Drug Discovery Platform Market Key Players:
Some of the key players operating in the cloud-based drug discovery platform market
IBM Corp, Accenture PLC, BioXcel Corporation, Cloud Pharmaceuticals, Inc., WuXi
AppTec (Shanghai) Co., Ltd., Dassault Systemes BIOVIA Ltd.